File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.18632/aging.202164
- Scopus: eid_2-s2.0-85099549719
- PMID: 33289700
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma
Title | SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma |
---|---|
Authors | |
Keywords | SNRPB hepatocellular carcinoma RNA splicing cancer stem cell glycolysis |
Issue Date | 2021 |
Publisher | Impact Journals LLC. The Journal's web site is located at http://www.impactaging.com |
Citation | Aging, 2021, v. 13 n. 1, p. 537-554 How to Cite? |
Abstract | Hepatocellular carcinoma (HCC) is one of the leading malignant diseases worldwide, but therapeutic targets for HCC are lacking. Here, we characterized a significant upregulation of Small Nuclear Ribonucleoprotein Polypeptides B and B1 (SNRPB) in HCC via qRT-PCR, western blotting, tissue microarray and public database analyses. Increased SNRPB expression was positively associated with adjacent organ invasion, tumor size, serum AFP level and poor HCC patient survival. Next, we transfected SNRPB into HCC cells to construct SNRPB-overexpressing cell lines, and short hairpin RNA targeting SNRPB was used to silence SNRPB in HCC cells. Functional studies showed that SNRPB overexpression could promote HCC cell malignant proliferation and stemness maintenance. Inversely, SNRPB knockdown in HCC cells caused inverse effects. Importantly, analysis of alternative splicing by RNA sequencing revealed that SNRPB promoted the formation of AKT3-204 and LDHA-220 splice variants, which activated the Akt pathway and aerobic glycolysis in HCC cells. In conclusion, SNRPB could serve as a prognostic predictor for patients with HCC, and it promotes HCC progression by inducing metabolic reprogramming. |
Persistent Identifier | http://hdl.handle.net/10722/300924 |
ISSN | 2023 Impact Factor: 3.9 2023 SCImago Journal Rankings: 1.180 |
PubMed Central ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhan, YT | - |
dc.contributor.author | Li, L | - |
dc.contributor.author | Zeng, TT | - |
dc.contributor.author | Zhou, NN | - |
dc.contributor.author | Guan, XY | - |
dc.contributor.author | Li, Y | - |
dc.date.accessioned | 2021-07-06T03:12:07Z | - |
dc.date.available | 2021-07-06T03:12:07Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Aging, 2021, v. 13 n. 1, p. 537-554 | - |
dc.identifier.issn | 1945-4589 | - |
dc.identifier.uri | http://hdl.handle.net/10722/300924 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is one of the leading malignant diseases worldwide, but therapeutic targets for HCC are lacking. Here, we characterized a significant upregulation of Small Nuclear Ribonucleoprotein Polypeptides B and B1 (SNRPB) in HCC via qRT-PCR, western blotting, tissue microarray and public database analyses. Increased SNRPB expression was positively associated with adjacent organ invasion, tumor size, serum AFP level and poor HCC patient survival. Next, we transfected SNRPB into HCC cells to construct SNRPB-overexpressing cell lines, and short hairpin RNA targeting SNRPB was used to silence SNRPB in HCC cells. Functional studies showed that SNRPB overexpression could promote HCC cell malignant proliferation and stemness maintenance. Inversely, SNRPB knockdown in HCC cells caused inverse effects. Importantly, analysis of alternative splicing by RNA sequencing revealed that SNRPB promoted the formation of AKT3-204 and LDHA-220 splice variants, which activated the Akt pathway and aerobic glycolysis in HCC cells. In conclusion, SNRPB could serve as a prognostic predictor for patients with HCC, and it promotes HCC progression by inducing metabolic reprogramming. | - |
dc.language | eng | - |
dc.publisher | Impact Journals LLC. The Journal's web site is located at http://www.impactaging.com | - |
dc.relation.ispartof | Aging | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | SNRPB | - |
dc.subject | hepatocellular carcinoma | - |
dc.subject | RNA splicing | - |
dc.subject | cancer stem cell | - |
dc.subject | glycolysis | - |
dc.title | SNRPB-mediated RNA splicing drives tumor cell proliferation and stemness in hepatocellular carcinoma | - |
dc.type | Article | - |
dc.identifier.email | Li, L: lilei728@HKUCC-COM.hku.hk | - |
dc.identifier.email | Guan, XY: xyguan@hku.hk | - |
dc.identifier.authority | Guan, XY=rp00454 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.18632/aging.202164 | - |
dc.identifier.pmid | 33289700 | - |
dc.identifier.pmcid | PMC7834993 | - |
dc.identifier.scopus | eid_2-s2.0-85099549719 | - |
dc.identifier.hkuros | 323259 | - |
dc.identifier.volume | 13 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 537 | - |
dc.identifier.epage | 554 | - |
dc.publisher.place | United States | - |